Posters
Evaluation of preloaded intraocular lens delivery system in patients with cataract surgery: a retrospective analysis
Poster Details
First Author: S.Acar TURKEY
Co Author(s): B. Torun Acar I. Torun
Abstract Details
Purpose:
To evaluate implantation characteristics of the new generation preloaded intraocular lens (IOL) delivery system and to report early clinical experience with preloaded hydrophobic acrylic IOL.
Setting:
Bati Goz Hospital, Istanbul, Turkey
Methods:
Retrospective analysis of 41 eyes of 41 patients who underwent cataract surgery from September 2015 to June 2016 was carried out. All the patients were implanted with hydrophobic acrylic IOL using preloaded delivery system (Eyecryl SERT, Biotech Vision Care, Ahmedabad, India). The incision size, ease of insertion, handling and unfolding time of IOL were assessed during surgery. Keratometry, manifest refraction, endothelial cell count, uncorrected visual acuity (UCVA) and best-corrected visual acuity (BCVA) at various distance, and contrast sensitivity were obtained at 1, 3 and 6 months after surgery. Adverse Events/complications observed during and after surgery were also recorded.
Results:
EYECRYL-SERT showed �â��excellent�â�� ease of insertion and handling in all 41(100%) patients. Unfolding time of IOL as 2.83�Â�±0.50 seconds. Corrected Distance Visual Acuity (CDVA), Corrected Intermediate Visual Acuity (CIVA) and Corrected Near Visual Acuity (CNVA) were 0.03�Â�±0.04 logMAR, 0.10�Â�±0.04 and 0.01�Â�±0.02 logMAR respectively after 6 months of surgery. Refractive spherical equivalence and endothelial cell count was decreased to -0.21�Â�±0.47 D and 2667.23�Â�±160.48 cells/mm2 respectively at 6 months after surgery. Low contrast sensitivity and high contrast sensitivity were 0.06 �Â�±0.06 logMAR and -0.05�Â�±0.06 logMAR respectively after 6 months of surgery.
Conclusions:
We found EYECRYL-SERT IOL delivery system ease of insertion and handling. Hydrophobic acrylic IOL was safely implanted via using EYECRYL SERT preloaded delivery system without any adverse events and improved visual acuity in cataract surgery patients while preserving visual quality over the 6-month follow-up period.
Financial Disclosure:
NONE
